Jeffrey Everitt
Dr. Jeffrey Everitt is the Worldwide Director of Comparative Biology &Medicine in the Department of Laboratory Animal Sciences at GlaxoSmithKline Pharmaceutical R&D. He also serves on the adjunct faculty in the Department of Pathology and Laboratory Medicine at the UNC School of Medicine in Chapel Hill, N.C. and in the College of Veterinary Medicine at North Carolina State University in Raleigh, NC. Dr. Everitt received his D.V.M. from Cornell University (1977) and completed a residency in pathology at the University of Pennsylvania
(1980). Prior to assuming his position at GlaxoSmithKline in 2002, Dr. Everitt spent over 17 years on the senior scientific staff of the CIIT Centers for Health Research (formerly the Chemical Industry Institute of Toxicology) where he led a multidisciplinary program that studied the health effects of inhaled particulate. Throughout his professional career, Dr. Everitt has been active in numerous professional societies, including service on the Executive Council of the Society of Toxicologic Pathology, and on the Council of the Inhalation Specialty Section and the Toxicologic and Exploratory Pathology Specialty Section of the Society of Toxicology. Dr. Everitt is a Diplomate of the American College of Veterinary Pathologists and a Diplomate of the American College Laboratory Animal Medicine. He has been a member of National Toxicology Program pathology working groups since 1985 and has served as a consultant in toxicologic pathology to numerous academic, industrial, and governmental organizations including NIH, USEPA, NIEHS, IARC, NTP,and ILSI. Dr. Everitt’s research interests include experimental and toxicologic pathology of the lung and kidney, particle-induced lung disease, and the development of animal models of human disease.